Hyperalgesia in rats following intracerebroventricular administration of endotoxin: effect of bradykinin B1 and B2 receptor antagonist treatment

Pain. 1996 May-Jun;65(2-3):211-9. doi: 10.1016/0304-3959(95)00195-6.


The present study investigated the development of thermal and mechanical hyperalgesia following intracerebroventricular (i.c.v.) injections of E. coli lipopolysaccharide (LPS). Hind paw withdrawal to von Frey filament stimulation and thermal withdrawal latencies were measured before and up to 24 or 48 h following an i.c.v. injection of LPS (dose range: 0.02--200 micrograms). Thermal and mechanical hyperalgesia were evident by 6 h after LPS injection. LPS-induced hyperalgesia was reversed by the B2 receptor antagonist, HOE 140 (10--30 pmol), when administered i.c.v. but not systemically (0.01--1 mmol/kg, i.v.). Central co-administration of the B1 receptor antagonists, des-Arg9-Leu8 Bk (0.1--1 nmol) or des-Arg10 HOE 140 (0.1--1 nmol) had no effect on thermal or mechanical hyperalgesia. LPS-induced hyperalgesia was also inhibited by indomethacin administered either i.c.v. (10 nmol) or i.v. (1 mumol/kg). These results indicate that administration of endotoxin to the CNS induces the development of hyperalgesia and that this response involves the activity of kinins, via the stimulation of centrally located B2 receptors, and the formation of prostanoids.

MeSH terms

  • Analysis of Variance
  • Animals
  • Biomechanical Phenomena
  • Bradykinin Receptor Antagonists*
  • Hyperalgesia / chemically induced*
  • Indomethacin / pharmacology
  • Injections, Intravenous
  • Injections, Intraventricular
  • Lipopolysaccharides
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Reaction Time / drug effects
  • Receptor, Bradykinin B1
  • Receptor, Bradykinin B2
  • Skin Temperature


  • Bradykinin Receptor Antagonists
  • Lipopolysaccharides
  • Receptor, Bradykinin B1
  • Receptor, Bradykinin B2
  • Indomethacin